News that a potential treatment for early stage Alzheimer’s disease can slow cognitive decline is a significant development in dementia research. About the drug Lecanemab is an antibody that is designed to remove toxic beta-amyloid deposits; proteins that build up in the brains of people with Alzheimer’s disease. Following phase 3 clinical trials, pharmaceutical companies […]

Many people living with dementia have sleep difficulties which can be troublesome for the person affected, their families and carers. Problems can include reduced and or disturbed sleep, nighttime awakening, wandering and excessive napping during the day. There are currently no effective treatments to help. Aim of the study Researchers from University College London (UCL) […]

In this blog for Dementia Action Week, Professor Martin Rossor reflects on how far dementia research has come, and looks ahead to how healthcare professionals, researchers and the public can take the next step together.